Начало・Списък с акции・Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc

Отворен

СекторЗдравеопазване

2.35 -3.69

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.41

Максимум

2.5

Ключови измерители
By Trading Economics
Приходи	14M -1M
Продажби	16M 21M
EPS	-0.003
Марж на печалбата	-4.943
Служители	81
EBITDA	15M 657K

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+102.01% upside

Дивиденти
By Acuity
Следващи печалби	6.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	324M 1B
Предишно отваряне	6.04
Предишно затваряне	2.35

Настроения в новините

By Acuity

34%

66%

130 / 340 Класиране в Healthcare

Lexicon Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

4.08.2026 г., 19:56 ч. UTC

Lexicon Pharmaceuticals shares are higher today, reflecting strong momentum amid easing inflation concerns from declining crude oil prices. No specific news was identified.

31.07.2026 г., 19:46 ч. UTC

Lexicon Pharmaceuticals Inc shares are lower today, reflecting broader market trends amid rising yields and crude oil prices contributing to inflation concerns.

30.07.2026 г., 23:11 ч. UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market hours. The decline follows broader market uncertainty after the Federal Reserve's interest rate decision.

29.07.2026 г., 21:02 ч. UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market trading, reflecting broader market declines amid rising oil prices and geopolitical tensions in the Middle East.

27.07.2026 г., 19:03 ч. UTC

Lexicon Pharmaceuticals Inc is trading lower today, breaking a trend of higher daily closes. Broader market declines and falling oil prices may influence sentiment.

24.07.2026 г., 20:07 ч. UTC

Lexicon Pharmaceuticals Inc shares are lower today, reversing from earlier gains amid broader market volatility influenced by falling oil prices and inflation concerns.

22.07.2026 г., 19:02 ч. UTC

Lexicon Pharmaceuticals Inc shares are lower today, continuing a decline since Tuesday's close. The stock remains below its 20-day moving average.

21.07.2026 г., 19:42 ч. UTC

Lexicon Pharmaceuticals is higher as the market gains momentum, driven by strong performances from major companies and a resurgence in semiconductor stocks.

20.07.2026 г., 19:06 ч. UTC

Lexicon Pharmaceuticals Inc shares are lower today, following three days of gains. Broader market declines are linked to rising US Treasury yields and oil prices above $90.

Сравнение с други в отрасъла

Ценова промяна

Lexicon Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

102.01% нагоре

12-месечна прогноза

Среден 5.03 USD 102.01%

Висок 6 USD

Нисък 3.1 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Lexicon Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

Купи

Задържане

Продай

Според 3 анализатори, дали борсови рейтинги на Lexicon Pharmaceuticals Inc през последните 3 месеца.

Настроение

By Acuity

130 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.